Risk and timing of cardiovascular death among patients with myelodysplastic syndromes

Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders associated with progression to leukemia and poor survival. Clonal hematopoiesis in people without an MDS diagnosis carries an increased risk of cardiovascular death. Many clonally restricted mutations are shared between pat...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood Adv
Главные авторы: Brunner, Andrew M., Blonquist, Traci M., Hobbs, Gabriela S., Amrein, Philip C., Neuberg, Donna S., Steensma, David P., Abel, Gregory A., Fathi, Amir T.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2017
Предметы:
Myeloid Neoplasia
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728287/
https://ncbi.nlm.nih.gov/pubmed/29296849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017010165
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы